Pharmaceutical Business review

American Diabetes Association slams stem cell veto

The American Diabetes Association (ADA) has been a strong supporter of the bill, which it believes would accelerate medical advancements by easing existing restrictions and supporting research that uses embryonic stem cells, while maintaining strict ethical guidelines. The association recently presented a petition, signed by approximately 11,000 Americans affected by diabetes, urging President Bush to sign the bill.

“This is a devastating setback for the 20.8 million American children and adults with diabetes – and those who love and care for them. We truly believe that embryonic stem cell research offers the greatest promise for a cure for diabetes,” commented Lawrence Smith, chair of the ADA.

“Despite bipartisan support in Congress, the backing of 70% of the American public, and the hopes and prayers of millions of individuals with diabetes and other debilitating diseases, the president has chosen the wrong path,” Mr Smith continued.